Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
暂无分享,去创建一个
Harold S Margolis | H. Margolis | M. Alter | G. Xia | D. Kruszon-Moran | G. Mcquillan | O. Nainan | Omana V Nainan | Miriam J Alter | Deanna Kruszon-Moran | Feng-Xiang Gao | Guoliang Xia | Geraldine McQuillan | F. Gao | F. Gao
[1] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[2] D. Vaira,et al. Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium , 2005, Journal of medical virology.
[3] P. Couzigou,et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study , 2005, Journal of viral hepatitis.
[4] P. Killenberg,et al. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. , 2004, The New England journal of medicine.
[5] M. Alter,et al. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti‐HCV , 2004, Transfusion.
[6] B. McMahon,et al. Epidemiology and risk factors for hepatitis C in Alaska Natives , 2004, Hepatology.
[7] J. Cleveland,et al. Guidelines for infection control in dental health-care settings--2003. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[8] P. Colson,et al. Genomic and phylogenetic analysis of hepatitis C virus isolates: A survey of 535 strains circulating in southern France , 2003, Journal of medical virology.
[9] A. Perelson,et al. Viral dynamics and response differences in HCV‐infected African American and white patients treated with IFN and ribavirin , 2003, Hepatology.
[10] M. Serra,et al. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage , 2003, Journal of viral hepatitis.
[11] M. Alter,et al. Prevention of spread of hepatitis C , 2002, Hepatology.
[12] C. Tiribelli,et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy , 2002, Journal of medical virology.
[13] J. Hoofnagle,et al. Optimal therapy of hepatitis C , 2002, Hepatology.
[14] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[15] David Collett,et al. Statistical inference for binary data , 2002 .
[16] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[17] O. Pybus,et al. The Epidemic Behavior of the Hepatitis C Virus , 2001, Science.
[18] J. Albrecht,et al. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. , 2000, Gastroenterology.
[19] Conrad,et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States , 2000, Journal of viral hepatitis.
[20] R. S. Ross,et al. Changes in the epidemiology of hepatitis C infection in Germany: Shift in the predominance of hepatitis C subtypes , 2000 .
[21] H J Alter,et al. Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.
[22] J. Kaldor,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[23] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[24] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[25] A. Costantino,et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community‐based survey in southern Italy , 1997, Hepatology.
[26] Randall G. Lee,et al. Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. , 1997, The Journal of infectious diseases.
[27] K. Reddy,et al. Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy , 1996, Annals of Internal Medicine.
[28] H. Margolis,et al. Sequence-specific, single-primer amplification and detection of PCR products for identification of hepatitis viruses. , 1996, Journal of virological methods.
[29] P. Simmonds,et al. Distribution of Hepatitis C Virus Genotypes Determined by Line Probe Assay in Patients with Chronic Hepatitis C Seen at Tertiary Referral Centers in the United States , 1996, Annals of Internal Medicine.
[30] D. Meijer,et al. Drug traffic in the hepatobiliary system. , 1996, Journal of hepatology.
[31] J. Pawlotsky,et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. , 1995, The Journal of infectious diseases.
[32] H. Smuts,et al. Genotyping of hepatitis C virus in South Africa , 1995, Journal of clinical microbiology.
[33] R. Purcell,et al. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.
[34] J. Hoofnagle,et al. Genotypic analysis of hepatitis C virus in American patients , 1994, Hepatology.
[35] S. Mishiro,et al. Genetic heterogeneity of hepatitis C virus. , 1994, Intervirology.
[36] E. Holmes,et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. , 1993, The Journal of general virology.
[37] J. Devereux,et al. A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..